GINKGO BIOWORKS HOLDINGS, INC. (DNA) Capital expenditures 2019–2025
GINKGO BIOWORKS HOLDINGS, INC. (DNA) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$7.7MFY2025 · since FY2019: $22.2M → $7.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $7.7M | -87.7% |
| FY2024 | $62.5M | +53.3% |
| FY2023 | $40.8M | -21.9% |
| FY2022 | $52.3M | -7.5% |
| FY2021 | $56.5M | -2.2% |
| FY2020 | $57.8M | +160.2% |
| FY2019 | $22.2M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice